When SGs are inhibited with cyclooxygenase 1/2 (COX1/2) inhibitors in KRAS-mutated colon cancers, researchers found that the cells were resensitized to oxaliplatin [118]. This evidence concerns the gene PTGS1 and malignant colon neoplasm.